EGFR and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), radiomics is employed to predict prognosis [8, 9], metastases [10, 11], histological subtypes [12], and expression of epidermal growth factor receptors [13] and partly accepted as a powerful method.